Is miR-29 an oncogene or tumor suppressor in CLL?

por Pekarsky, Yuri, Croce, Carlo M.
Publicado 2010

PDCD1 (PD-1) is a direct target of miR-15a-5p and miR-16-5p

por Palamarchuk, Alexey, Tsyba, Liudmyla, Tomasello, Luisa, Pekarsky, Yuri, Croce, Carlo M.
Publicado 2022

Common Fragile Site Tumor Suppressor Genes and Corresponding Mouse Models of Cancer

por Drusco, Alessandra, Pekarsky, Yuri, Costinean, Stefan, Antenucci, Anna, Conti, Laura, Volinia, Stefano, Aqeilan, Rami I., Huebner, Kay, Zanesi, Nicola
Publicado 2011

A large fraction of trisomy 12, 17p(−), and 11q(−) CLL cases carry unidentified microdeletions of miR-15a/16-1

por Pepe, Felice, Rassenti, Laura Z., Pekarsky, Yuri, Labanowska, Jadwiga, Nakamura, Tatsuya, Nigita, Giovanni, Kipps, Thomas J., Balatti, Veronica, Croce, Carlo M.
Publicado 2022

miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eμ-TCL1 mouse model

por Bresin, Antonella, Callegari, Elisa, D'Abundo, Lucilla, Cattani, Caterina, Bassi, Cristian, Zagatti, Barbara, Narducci, M. Grazia, Caprini, Elisabetta, Pekarsky, Yuri, Croce, Carlo M., Sabbioni, Silvia, Russo, Giandomenico, Negrini, Massimo
Publicado 2015

MicroRNA Profiles Discriminate among Colon Cancer Metastasis

por Drusco, Alessandra, Nuovo, Gerard J., Zanesi, Nicola, Di Leva, Gianpiero, Pichiorri, Flavia, Volinia, Stefano, Fernandez, Cecilia, Antenucci, Anna, Costinean, Stefan, Bottoni, Arianna, Rosito, Immacolata A., Liu, Chang-Gong, Burch, Aaron, Acunzo, Mario, Pekarsky, Yuri, Alder, Hansjuerg, Ciardi, Antonio, Croce, Carlo M.
Publicado 2014